Mostrar el registro sencillo del ítem

dc.contributor.authorOtero-Ortega, L.
dc.contributor.authorGutiérrez-Fernández, M.
dc.contributor.authorRamos-Cejudo, J.
dc.contributor.authorRodríguez-Frutos, B.
dc.contributor.authorFuentes, B.
dc.contributor.authorSobrino Moreiras, Tomas 
dc.contributor.authorHernanz, T. N.
dc.contributor.authorCampos Pérez, Francisco 
dc.contributor.authorLópez, J. A.
dc.contributor.authorCerdán, S.
dc.contributor.authorVázquez, J.
dc.contributor.authorDiéz-Tejedor, E.
dc.date.accessioned2017-06-07T07:35:34Z
dc.date.available2017-06-07T07:35:34Z
dc.date.issued2015
dc.identifier.issn1757-6512
dc.identifier.urihttp://hdl.handle.net/20.500.11940/8311
dc.description.abstractINTRODUCTION: Despite its high incidence, nerve fiber (axon and myelin) damage after cerebral infarct has not yet been extensively investigated. The aim of this study was to investigate white matter repair after adipose-derived mesenchymal stem cell (ADMSC) administration in an experimental model of subcortical stroke. Furthermore, we aimed to analyze the ADMSC secretome and whether this could be implicated in this repair function. METHODS: An animal model of subcortical ischemic stroke with white matter affectation was induced in rats by injection of endothelin-1. At 24 hours, 2 x 10(6) ADMSC were administered intravenously to the treatment group. Functional evaluation, lesion size, fiber tract integrity, cell death, proliferation, white matter repair markers (Olig-2, NF, and MBP) and NogoA were all studied after sacrifice (7 days and 28 days). ADMSC migration and implantation in the brain as well as proteomics analysis and functions of the secretome were also analyzed. RESULTS: Neither ADMSC migration nor implantation to the brain was observed after ADMSC administration. In contrast, ADMSC implantation was detected in peripheral organs. The treatment group showed a smaller functional deficit, smaller lesion area, less cell death, more oligodendrocyte proliferation, more white matter connectivity and higher amounts of myelin formation. The treated animals also showed higher levels of white matter-associated markers in the injured area than the control group. Proteomics analysis of the ADMSC secretome identified 2,416 proteins, not all of them previously described to be involved in brain plasticity. CONCLUSIONS: White matter integrity in subcortical stroke is in part restored by ADMSC treatment; this is mediated by repair molecular factors implicated in axonal sprouting, remyelination and oligodendrogenesis. These findings are associated with improved functional recovery after stroke.
dc.description.sponsorshipMinisterio de Ciencia y Competitividad de España. Instituto de Salud Carlos III(ISCIII)
dc.description.sponsorshipComisión Europea
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAnimals
dc.subject.meshApoptosis
dc.subject.meshBasic Helix-Loop-Helix Transcription Factors
dc.subject.meshCell Differentiation
dc.subject.meshCell Movement
dc.subject.meshCell Proliferation
dc.subject.meshDiffusion Tensor Imaging
dc.subject.meshDisease Models, Animal
dc.subject.meshEndothelin-1
dc.subject.meshMagnetic Resonance Imaging
dc.subject.meshMale
dc.subject.meshMesenchymal Stem Cell Transplantation
dc.subject.meshMesenchymal Stem Cells
dc.subject.meshMyelin Basic Protein
dc.subject.meshMyelin Proteins
dc.subject.meshNerve Tissue Proteins
dc.subject.meshOligodendrocyte Transcription Factor 2
dc.subject.meshOligodendroglsm
dc.subject.meshProteois
dc.subject.meshProteomics
dc.subject.meshRats
dc.subject.meshRats, Sprague-Dawley
dc.subject.meshRecovery of Function
dc.subject.meshStropy
dc.subject.meshWhite Mattgy
dc.titleWhite matter injury restoration after stem cell administration in subcortical ischemic stroke
dc.typeArtigoes
dc.authorsophosOtero-Ortega, L.
dc.authorsophosGutiérrez-Fernández, M.
dc.authorsophosRamos-Cejudo, J.
dc.authorsophosRodríguez-Frutos, B.
dc.authorsophosFuentes, B.
dc.authorsophosSobrino, T.
dc.authorsophosHernanz, T. N.
dc.authorsophosCampos, F.
dc.authorsophosLópez, J. A.
dc.authorsophosCerdán, S.
dc.authorsophosVázquez, J.
dc.authorsophosDiéz-Tejedor, E.
dc.identifier.doi10.1186/s13287-015-0111-4
dc.identifier.isi358480500001
dc.identifier.pmid26088123
dc.identifier.sophos19649
dc.issue.number1
dc.journal.titleStem Cell Research & Therapy
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Neuroloxía
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial121
dc.relation.projectIDISCIII/PS12/01754
dc.relation.projectIDISCIII/PI11/00909
dc.relation.projectIDISCIII/RD12/0014
dc.relation.projectIDISCIII/SAF2010-37926
dc.relation.projectIDISCIII/ProteoRed-PT13/0001/0017
dc.relation.projectIDISCIII/CD12/00706
dc.relation.projectIDISCIII/CP12/03121
dc.relation.projectIDISCIII/CP14/00154
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number6


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional